Ir a las Transacciones
Salud | Logística

Decopharma has been acquired by CTT

Decopharma has been acquired by CTT – Correios de Portugal, strengthening its position as a national reference in pharmaceutical logistics solutions. This strategic transaction marks an important step in the consolidation of the specialized logistics sector in Portugal, combining Decopharma’s expertise in healthcare logistics with CTT’s robust infrastructure and growth potential.

Decopharma provides end-to-end logistics services for the pharmaceutical and healthcare sectors, covering medicines such as over-the-counter products (OTC), nutraceuticals, cosmetics and veterinary items, as well as medical devices including hospital equipment, consumables and laboratory supplies. With a team of around 30 employees, the company manages the entire logistics chain — from goods reception and storage to quality control, order processing and distribution.

CTT – Correios de Portugal is a leading provider of integrated logistics and distribution services, offering parcel delivery, express shipping and e-commerce solutions. Backed by a nationwide infrastructure and specialized subsidiaries like CTT Expresso, the company enables efficient last-mile delivery and supply chain operations for businesses across various sectors.

Oaklins’ team in Portugal advised the shareholders of Decopharma in this transaction.

Partes

Contáctese con el equipo de la transacción

Diogo Torrado

Socio
Lisboa, Portugal
Oaklins Portugal

Mariana Gomes

Asociado Director
Lisboa, Portugal
Oaklins Portugal

Transacciones relacionadas

Medicija has acquired Saulės Šeimos Medicinos Centras
Salud

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Aprenda más
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Salud

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Aprenda más
IXICO has completed a fundraising
Salud

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Aprenda más